These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2573194)

  • 1. [Bopindolol does not affect normal glucose and lipid metabolism in hypertensive patients].
    Fedelesová V; Spustová V; Hucková M; Kovác G
    Vnitr Lek; 1989 Sep; 35(9):873-9. PubMed ID: 2573194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Celiprolol improves glucose metabolism in essential hypertension].
    Oksa A; Fedelesová V; Spustová V; Dzúrik R
    Vnitr Lek; 1998 Feb; 44(2):63-7. PubMed ID: 9820078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
    Widimský J; Lefflerová K; Dvorák I; Fedelesová V; Lupínek Z; Mayer O; Pinterová E
    Am J Cardiol; 1991 Apr; 67(10):36B-42B. PubMed ID: 1673580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
    Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profile improvement following celiprolol.
    Herrmann JM; von Heyman F; Freischütz G
    J Int Med Res; 1988; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipid fractions during bopindolol treatment in hypertensive patients.
    van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S42-4. PubMed ID: 2439818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
    Bagatin J; Sardelić S; Pivac N; Polić S; Ljutic D; Rakic D; Naranca M; Bojić L; Kovacić Z; Rumboldt Z
    Int J Clin Pharmacol Res; 1998; 18(2):73-8. PubMed ID: 9675624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
    Honorato J; Galende I; Catalán M; Azanza JR
    Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
    Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
    Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
    Malminiemi K; Lahtela JT; Huupponen R
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.
    Fuh MM; Shieh SM; Wu DA; Chen YD; Reaven GM
    Arch Intern Med; 1987 Jun; 147(6):1035-8. PubMed ID: 3296980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J; Chanu B; Bakir R; Sauvanet JP
    J Pharmacol; 1983; 14 Suppl 2():183-99. PubMed ID: 6138467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.